We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.68B
AUM Growth
+$514M
Cap. Flow
+$496M
Cap. Flow %
18.53%
Top 10 Hldgs %
8.05%
Holding
1,939
New
669
Increased
399
Reduced
301
Closed
563

Top Buys

Rank Stock Value
1
APA icon
APA Corp
APA
+$26.5M
2
IBM icon
IBM
IBM
+$23.1M
3
PEP icon
PepsiCo
PEP
+$20.4M
4
ESRX
Express Scripts Holding Company
ESRX
+$19.3M
5
KMI icon
Kinder Morgan
KMI
+$18.5M

Sector Composition

Rank Sector Weight
1 Technology 15.21%
2 Healthcare 12.21%
3 Consumer Discretionary 11.76%
4 Industrials 11.24%
5 Energy 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRR
1351
DELISTED
Star Equity Holdings
STRR
$45K ﹤0.01%
208
-109
-34% -$21.4K
CDXS icon
1352
Codexis
CDXS
$136M
$44K ﹤0.01%
+17,646
New +$42.1K
LEE icon
1353
Lee Enterprises
LEE
$177M
$44K ﹤0.01%
+1,212
New +$42.4K
FRBK
1354
DELISTED
Republic First Bancorp Inc
FRBK
$42K ﹤0.01%
+11,320
New +$44K
QRHC icon
1355
Quest Resource Holding
QRHC
$28.2M
$41K ﹤0.01%
+3,625
New +$42.2K
AT
1356
DELISTED
Atlantic Power Corporation
AT
$39K ﹤0.01%
+14,702
New +$33.9K
VTSS
1357
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$38K ﹤0.01%
+10,136
New +$34.8K
SEED icon
1358
Origin Agritech
SEED
$11.9M
$37K ﹤0.01%
+2,563
New +$44.4K
ROSG
1359
DELISTED
Rosetta Genomics Ltd.
ROSG
$37K ﹤0.01%
+1,374
New +$44.6K
BSTG
1360
DELISTED
Biostage, Inc. Common Stock
BSTG
$36K ﹤0.01%
+11,440
New +$56.7K
MBOT icon
1361
Microbot Medical
MBOT
$113M
$35K ﹤0.01%
+23
New +$41.8K
PSHG icon
1362
Performance Shipping
PSHG
$22.5M
0
BBLU
1363
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
$35K ﹤0.01%
+33,000
New +$52.3K
RIC
1364
DELISTED
Richmont Mines Inc.
RIC
$34K ﹤0.01%
+10,854
New +$29.1K
AOI
1365
DELISTED
Alliance One International
AOI
$34K ﹤0.01%
2,155
+910
+73% +$16.9K
ATRS
1366
DELISTED
Antares Pharma, Inc.
ATRS
$32K ﹤0.01%
12,497
-53,368
-81% -$120K
VXRT
1367
DELISTED
Vaxart
VXRT
$31K ﹤0.01%
1,289
-164
-11% -$4.2K
MNOV icon
1368
MediciNova
MNOV
$65.5M
$30K ﹤0.01%
+10,099
New +$34.2K
AXTI icon
1369
AXT Inc
AXTI
$2.8B
$29K ﹤0.01%
+10,655
New +$26.2K
AMD icon
1370
Advanced Micro Devices
AMD
$741B
$27K ﹤0.01%
+10,253
New +$28.2K
GAU
1371
Galiano Gold
GAU
$455M
$26K ﹤0.01%
17,465
+1,824
+12% +$3.14K
CVO
1372
DELISTED
Cenevo, Inc.
CVO
$26K ﹤0.01%
+1,566
New +$26.1K
AMCF
1373
DELISTED
ANDATEE CHINA MARINE FUEL SVCS CORP COM STK (DE)
AMCF
$26K ﹤0.01%
+17,080
New +$32.1K
ENTR
1374
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$26K ﹤0.01%
10,373
-7,500
-42% -$18.2K
IMNP
1375
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$19K ﹤0.01%
+510
New +$27.4K

Similar funds

A.R.T. Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, A.R.T. Advisors held 1,939 positions worth $2.68B, up 24% from $2.16B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

A.R.T. Advisors deployed $496M of net new capital in Q4 2014, opening 669 new positions and adding to 399 existing holdings. Its largest new stake was APA Corp: 372,860 shares worth $23.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was TIME WARNER CABLE INC NEW COM STK, an estimated $21.8M trimmed.

  • A.R.T. Advisors's largest Q4 2014 buy was APA Corp: 372,860 shares worth $23.4M.
  • A.R.T. Advisors added most to Express Scripts Holding Company in Q4 2014, an estimated $19.3M increase.
  • A.R.T. Advisors's biggest Q4 2014 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $21.8M.
  • A.R.T. Advisors fully exited Shire pic in Q4 2014, selling an estimated $24M.
  • A.R.T. Advisors's ten largest holdings make up 8.1% of its $2.68B portfolio in Q4 2014.
  • A.R.T. Advisors opened 669 new positions and closed 563 in Q4 2014.
  • A.R.T. Advisors's portfolio value rose 24% quarter-over-quarter to $2.68B.

Based on A.R.T. Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.